Overview
Current Appointments & Affiliations
Associate Professor of Biostatistics & Bioinformatics
·
2021 - Present
Biostatistics & Bioinformatics, Division of Biostatistics,
Biostatistics & Bioinformatics
Member of the Duke Cancer Institute
·
2010 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Isavuconazonium or posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia.
Journal Article J Oncol Pharm Pract · April 2024 BACKGROUND: Invasive fungal infection (IFI) prophylaxis is recommended in patients with acute myeloid leukemia (AML) during induction chemotherapy. Posaconazole (POSA) is the recommended agent of choice; however, this medication can be associated with QTc ... Full text Link to item CiteComparison of differing dose levels of methotrexate for patients with primary central nervous system lymphoma.
Journal Article J Oncol Pharm Pract · April 2024 INTRODUCTION: It has long been established that high-dose methotrexate is an essential part of therapy for primary central nervous system lymphoma. When regimens utilizing high-dose methotrexate were first studied, a dose of 8 g/m2 was used. More recently, ... Full text Link to item CiteHeightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.
Journal Article Blood Adv · February 13, 2024 Chronic graft-versus-host disease (cGVHD) is a debilitating, autoimmune-like syndrome that can occur after allogeneic hematopoietic stem cell transplantation. Constitutively activated B cells contribute to ongoing alloreactivity and autoreactivity in patie ... Full text Open Access Link to item CiteRecent Grants
Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis
ResearchConsultant · Awarded by National Institutes of Health · 2023 - 2028Promoting T cell recovery after radiation injury with long-acting interleukin 7
ResearchStatistician · Awarded by National Institutes of Health · 2024 - 2027Racial and Ethnic Differences in the Real-World Clinical Outcomes of IDH1 and IDH2 Inhibitors in Acute Myeloid Leukemia
ResearchStatistician · Awarded by University of North Carolina - Chapel Hill · 2024 - 2026View All Grants
Education, Training & Certifications
University of Michigan, Ann Arbor ·
2008
Ph.D.